NuEyes: Using Virtual Reality to Improve Vision for Achromatopsia, Congenital Nystagmus & Macular Degeneration Patients

An Idea Sometimes life leads us down unexpected paths. Mark Greget founded a medical device distribution company. That was his plan. But after interacting with patients through his work, he…

Continue Reading NuEyes: Using Virtual Reality to Improve Vision for Achromatopsia, Congenital Nystagmus & Macular Degeneration Patients
Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU
ColiN00B / Pixabay

Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU

According to a story from BioPortfolio, the gene therapy company bluebird bio, Inc. recently announced that its gene therapy ZYNTEGLO™ has earned conditional marketing authorization in the European Union from…

Continue Reading Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU

The Challenge: He is A Father, A Caregiver and A Scientist Trying to Save his Son and Others With ME/CFS or Chronic Fatigue Syndrome

  Ron Davis and his gene-sequencing technologies were mentioned years ago in The Atlantic alongside Elon Musk (SpaceX) and Jeff Bezos of Amazon fame. Since then, Davis has amassed over…

Continue Reading The Challenge: He is A Father, A Caregiver and A Scientist Trying to Save his Son and Others With ME/CFS or Chronic Fatigue Syndrome
Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy
courtesy of US Gov't

Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy

In a letter to Dr. Norman Sharpless, the acting commissioner of the Food and Drug Administration since April 5, Senator Ted Cruz encouraged the federal agency to expand the number…

Continue Reading Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy
Congressmen Introduce Bill to Help Chronic Inflammatory Demyelinating Polyneuropathy Patients and Others
skeeze / Pixabay

Congressmen Introduce Bill to Help Chronic Inflammatory Demyelinating Polyneuropathy Patients and Others

According to a story from the website of Oregon rep Earl Blumenauer, Blumenauer (D-OR) along with fellow congressmen George Holding (R-NC) and G. K. Butterfield (D-NC) have introduced a bill…

Continue Reading Congressmen Introduce Bill to Help Chronic Inflammatory Demyelinating Polyneuropathy Patients and Others

The First Therapy in 15 Years has just Been Approved by the FDA for Malignant Pleural Mesothelioma!

The FDA has just approved the very first therapy for malignant pleural mesothelioma (MPM) in more than 15 years. It is the NovoTTF-100L System, developed by Novocure. Not only is…

Continue Reading The First Therapy in 15 Years has just Been Approved by the FDA for Malignant Pleural Mesothelioma!

The Cure Rare Disease Foundation is Trying to Change the “One Size Fits All” Approach Toward Treatment

The Cure Rare Disease Foundation The Cure Rare Disease Foundation's mission is to increase collaborative efforts between researchers in order to accelerate the development of customized therapies for individuals living with…

Continue Reading The Cure Rare Disease Foundation is Trying to Change the “One Size Fits All” Approach Toward Treatment
Utility of Allogeneic Stem Cell Transplant in Non-Hodgkin Lymphoma Unclear, Report Says
sasint / Pixabay

Utility of Allogeneic Stem Cell Transplant in Non-Hodgkin Lymphoma Unclear, Report Says

According to a story from Science Daily, a review of studies focused on allogeneic stem cell transplants as a treatment for non-Hodgkin lymphoma found that it wasn't possible to conclude…

Continue Reading Utility of Allogeneic Stem Cell Transplant in Non-Hodgkin Lymphoma Unclear, Report Says

An In-Depth Discussion About FDA Oversight of Diagnostic Tests and the Effect of Inaccurate Tests on Patients

  Newly diagnosed patients may decide to either receive medical treatment or forego treatment based on the results of their diagnostic test.  As recently reported in PEW, although it is…

Continue Reading An In-Depth Discussion About FDA Oversight of Diagnostic Tests and the Effect of Inaccurate Tests on Patients

A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered

Claudia Stäubert and her team of researchers at the University of Leipzig have just reported noteworthy findings which could impact the future treatment of inflammatory diseases. Lactic acid bacteria, or…

Continue Reading A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered